MENU
+Compare
IBMT
ETF ticker: BATS
AS OF
Oct 24 closing price
Price
$25.98
Change
+$0.01 (+0.04%)

IBMT iShares iBonds Dec 2031 Term Muni Bd ETF Forecast, Technical & Fundamental Analysis

The investment seeks to track the investment results of the S&P AMT-Free Municipal Series Callable-Adjusted Dec 2031 Index... Show more

IBMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IBMT with price predictions
Oct 24, 2025

IBMT in +0.58% Uptrend, rising for three consecutive days on October 13, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IBMT advanced for three days, in of 23 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 3 cases where IBMT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 10, 2025. You may want to consider a long position or call options on IBMT as a result. In of 5 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis
View a ticker or compare two or three
IBMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MunicipalBondFunds

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMPS6.280.04
+0.64%
COMPASS Pathways Plc
HCWB3.920.02
+0.51%
HCW Biologics Inc
GEN27.220.03
+0.11%
Gen Digital
ZGN10.440.01
+0.10%
Ermenegildo Zegna NV
CNTX1.26-0.02
-1.56%
Context Therapeutics